Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| Xerosis | 1% - 9% | x | x | x | ||
| Tingling sensation | 1% - 29% | x | x | x | x | |
| Pruritus | 0% - 11% | x | x | x | x | |
| Dry skin | 1% - 9% | x | x | x | ||
| Stinging | 1% - 16% | x | x | x | x | |
| Erythema | 1% - 2% | x | x | |||
| Dermatitis contact | 0% - 1% | x | x | x | x | |
| Oedema | 0% - 1% | x | x | x | ||
| Acne | 0% - 1% | x | x | x | ||
| Iridocyclitis | postmarketing | x | x | x | ||
| Asthma | x | x | x | x | ||
| Dermatitis | x | |||||
| Rash | x | |||||
| Herpes labialis | x | x | x | x | ||
| Hypersensitivity | x | |||||
| Hypertrichosis | x | x | x | x | ||
| Vitiligo | x | x | x | x | ||
| Application site reaction | x | x | x | |||
| Leukoderma | x | x | x | x | ||
| Keratosis pilaris | x | x | x | x | ||
| Redness | x | x | x | |||
| Localized exfoliation | x | |||||
| Phototoxicity | x | x | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |